Table 2.
Anthropometric and physiological parameters of participants at baseline, week 6 and week 12 of intervention with C. forskohlii extract (n = 15 in each group).
| Parameter | Study Group | Baseline | Week 6 | Week 12 | p Value | |
|---|---|---|---|---|---|---|
| Weight | Experimental | 89.5 ± 13.2 | 88.6 ± 12 | 88 ± 11.4 | Group | 0.3 |
| (kg) | Placebo | 92.9 ± 21.2 | 92.2 ± 20.5 | 91.5 ± 21 | Time | 0.3 |
| Interaction | 1 | |||||
| BMI | Experimental | 31.8 ± 3.9 | 30.7 ± 3.6 | 30.4 ± 3.4 | Group | 0.7 |
| (kg/m2) | Placebo | 32.8 ± 6.5 | 32.6 ± 6.4 | 32.2 ± 6.2 | Time | 0.1 |
| Interaction | 1 | |||||
| Waist | Experimental | 106.9 ± 11.7 | 103.6 ± 9.8 | 102.4 ± 11.3 | Group | 1.0 |
| (cm) | Placebo | 106.1 ± 11.2 | 103.7 ± 11.6 | 102.6 ± 15 * | Time | 0.02 |
| Interaction | 0.7 | |||||
| Hip | Experimental | 112.3 ± 5.9 | 109.8 ± 5 | 108.9 ± 5.4 | Group | 0.3 |
| (cm) | Placebo | 115.3 ± 13.2 | 113.8 ± 11.9 | 112.3 ± 12.6 * | Time | 0.01 |
| Interaction | 0.6 | |||||
| WHR | Experimental | 0.95 ± 0.09 | 0.94 ± 0.08 | 0.94 ± 0.08 | Group | 0.3 |
| Placebo | 0.92 ± 0.08 | 0.91 ± 0.09 | 0.91 ± 0.08 | Time | 0.3 | |
| Interaction | 0.8 | |||||
| Systolic BP | Experimental | 125 ± 17 | 128 ± 13 | 125 ± 13 | Group | 0.3 |
| (mmHg) | Placebo | 128 ± 13 | 132 ± 12 | 130 ± 10 | Time | 0.4 |
| Interaction | 0.8 | |||||
| Diastolic BP | Experimental | 79 ± 8 | 79 ± 9 | 77 ± 9 | Group | 0.6 |
| (mmHg) | Placebo | 83 ± 8 | 80 ± 8 | 78 ± 10 | Time | 0.1 |
| Interaction | 0.9 | |||||
| Heart Rate | Experimental | 74 ± 13 | 75 ± 12 | 73 ± 13 | Group | 0.3 |
| (bpm) | Placebo | 76 ± 14 | 73 ± 11 | 74 ± 12 | Time | 0.1 |
| Interaction | 0.6 | |||||
Values are expressed as mean ± SD. * p < 0.05, compared to baseline for each intervention. WHR, waist to hip ratio; BP, blood pressure.